Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Stocosil

Stocosil
2014 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Angel LATEST DEAL TYPE
$2.03M LATEST DEAL AMOUNT
Description

Developer of anti-hypertension drugs. The company specializes in developing personalized dosing for anti-hypertension.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Delivery
Other Healthcare Services
Primary Office
  • 17870 Castleton Street
  • Suite 250
  • Industry, CA 91748
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Stocosil’s full profile, request a free trial.

Stocosil Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 12-Jul-2016 $2.03M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Stocosil Executive Team (3)

Name Title Board
Seat
Contact
Info
Pyng Soon Chief Executive Officer
Vuong Trieu Ph.D Chairman & Chief Regulatory Officer
Chulho Park Ph.D Chief Business Officer

Stocosil Board Members (1)

Name Representing Role Since Contact
Info
Vuong Trieu Ph.D Self Chairman & Chief Regulatory Officer 000 0000